The molecule is an azo derivative of an active molecule (UR-12715, anti-TNFalpha and PAF antagonist ) and 5-aminosalicylic acid (5-ASA), the gold standard treatment for mild to moderate ulcerative colitis. More
A non-pathogenic strain of Burkholderia cepacia provides an opportunity to develop a live vaccine to prevent Bcc infection in CF and critically ill patients, which would dramatically improve the quality of life and life expectancy of these patients. More
These hybrid antibody molecules can be engineered with a variety of small synthetic molecules, and the combination of immunogenic properties results in compounds with powerful target destruction or imaging capabilities. More
US based researchers seek licensing partners for their dendritic cell based vaccine technology, which has applications in the treatment of cancer, amongst other diseases. More
All rights reserved. Terms and Conditions | Contact us
